Drugmakers are asking the US Supreme Court to vacate a ruling that allowed a lawsuit over their alleged financial ties to a series of terrorist attacks.
The petitioners are 21 companies from five corporate families—
The plaintiffs—victims of the attacks and family members—said that the companies violated the Anti-Terrorism Act, which recognizes a private right of action for US nationals injured by acts of international terrorism. The drugmakers financially supported an Iraqi group that was responsible for attacks between 2005 ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.